Digital therapeutics company Big Health announced it acquired Limbix, a maker of prescription digital therapeutics aimed at treating depression in teens and young adults.
Limbix is the creator of SparkRx, a PDTx that uses the principles of cognitive behavioral therapy to address depression in teens and young adults ages 13 to 22.
The self-guided CBT-based treatment was released in October 2021...